Literature DB >> 18587560

Reduced tricarboxylic acid cycle flux in type 2 diabetes mellitus?

P Schrauwen1, M K C Hesselink.   

Abstract

AIMS/HYPOTHESIS: Mitochondrial dysfunction has been postulated to underlie muscular fat accumulation, leading to muscular insulin sensitivity and ultimately type 2 diabetes mellitus. Here we re-interpret previously published data on [(13)C]acetate recovery in breath gas obtained during exercise in type 2 diabetic patients and control individuals.
METHODS: When infusing [(13)C]palmitate to estimate fat oxidation, part of the label is lost in exchange reactions of the tricarboxylic acid (TCA) cycle. To correct for this loss of label, an acetate recovery factor (ARF) has previously been used, assuming that 100% of the exogenously provided acetate will enter the TCA cycle. The recovery of acetate in breath gas depends on the TCA cycle activity, hence providing an indirect measure of the latter and a marker of mitochondrial function.
RESULTS: Re-evaluation of the available literature reveals that the ARF during exercise is highest in lean, healthy individuals, followed by obese individuals and type 2 diabetic patients. CONCLUSIONS/
INTERPRETATION: Revisiting previously published findings on the ARF during exercise in type 2 diabetic patients reveals a reduction in muscular TCA cycle flux, reflecting mitochondrial dysfunction, in these patients. How mitochondrial dysfunction is related to type 2 diabetes mellitus-cause or consequence-requires further study.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18587560      PMCID: PMC2516188          DOI: 10.1007/s00125-008-1069-x

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  11 in total

1.  Determinants of the acetate recovery factor: implications for estimation of [13C]substrate oxidation.

Authors:  P Schrauwen; E E Blaak; D P Van Aggel-Leijssen; L B Borghouts; A J Wagenmakers
Journal:  Clin Sci (Lond)       Date:  2000-05       Impact factor: 6.124

2.  Skeletal muscle mitochondrial functions, mitochondrial DNA copy numbers, and gene transcript profiles in type 2 diabetic and nondiabetic subjects at equal levels of low or high insulin and euglycemia.

Authors:  Yan W Asmann; Craig S Stump; Kevin R Short; Jill M Coenen-Schimke; Zengkui Guo; Maureen L Bigelow; K Sreekumaran Nair
Journal:  Diabetes       Date:  2006-12       Impact factor: 9.461

3.  Plasma free Fatty Acid uptake and oxidation are already diminished in subjects at high risk for developing type 2 diabetes.

Authors:  M Mensink; E E Blaak; M A van Baak; A J Wagenmakers; W H Saris
Journal:  Diabetes       Date:  2001-11       Impact factor: 9.461

4.  Impaired in vivo mitochondrial function but similar intramyocellular lipid content in patients with type 2 diabetes mellitus and BMI-matched control subjects.

Authors:  V B Schrauwen-Hinderling; M E Kooi; M K C Hesselink; J A L Jeneson; W H Backes; C J A van Echteld; J M A van Engelshoven; M Mensink; P Schrauwen
Journal:  Diabetologia       Date:  2006-11-09       Impact factor: 10.122

5.  Impaired mitochondrial substrate oxidation in muscle of insulin-resistant offspring of type 2 diabetic patients.

Authors:  Douglas E Befroy; Kitt Falk Petersen; Sylvie Dufour; Graeme F Mason; Robin A de Graaf; Douglas L Rothman; Gerald I Shulman
Journal:  Diabetes       Date:  2007-02-07       Impact factor: 9.461

6.  Substrate utilization in non-obese Type II diabetic patients at rest and during exercise.

Authors:  L B Borghouts; A J M Wagenmakers; P L L Goyens; H A Keizer
Journal:  Clin Sci (Lond)       Date:  2002-12       Impact factor: 6.124

7.  Impaired mitochondrial activity in the insulin-resistant offspring of patients with type 2 diabetes.

Authors:  Kitt Falk Petersen; Sylvie Dufour; Douglas Befroy; Rina Garcia; Gerald I Shulman
Journal:  N Engl J Med       Date:  2004-02-12       Impact factor: 91.245

8.  A new correction factor for use in tracer estimations of plasma fatty acid oxidation.

Authors:  L S Sidossis; A R Coggan; A Gastaldelli; R R Wolfe
Journal:  Am J Physiol       Date:  1995-10

9.  Intramyocellular triglyceride content is a determinant of in vivo insulin resistance in humans: a 1H-13C nuclear magnetic resonance spectroscopy assessment in offspring of type 2 diabetic parents.

Authors:  G Perseghin; P Scifo; F De Cobelli; E Pagliato; A Battezzati; C Arcelloni; A Vanzulli; G Testolin; G Pozza; A Del Maschio; L Luzi
Journal:  Diabetes       Date:  1999-08       Impact factor: 9.461

10.  Patients with type 2 diabetes have normal mitochondrial function in skeletal muscle.

Authors:  R Boushel; E Gnaiger; P Schjerling; M Skovbro; R Kraunsøe; F Dela
Journal:  Diabetologia       Date:  2007-02-15       Impact factor: 10.122

View more
  14 in total

1.  The proteomic signature of insulin-resistant human skeletal muscle reveals increased glycolytic and decreased mitochondrial enzymes.

Authors:  J Giebelstein; G Poschmann; K Højlund; W Schechinger; J W Dietrich; K Levin; H Beck-Nielsen; K Podwojski; K Stühler; H E Meyer; H H Klein
Journal:  Diabetologia       Date:  2012-01-27       Impact factor: 10.122

2.  Acylcarnitines as markers of exercise-associated fuel partitioning, xenometabolism, and potential signals to muscle afferent neurons.

Authors:  Jie Zhang; Alan R Light; Charles L Hoppel; Caitlin Campbell; Carol J Chandler; Dustin J Burnett; Elaine C Souza; Gretchen A Casazza; Ronald W Hughen; Nancy L Keim; John W Newman; Gary R Hunter; Jose R Fernandez; W Timothy Garvey; Mary-Ellen Harper; Oliver Fiehn; Sean H Adams
Journal:  Exp Physiol       Date:  2016-12-12       Impact factor: 2.969

3.  Nine months of combined training improves ex vivo skeletal muscle metabolism in individuals with type 2 diabetes.

Authors:  Lauren M Sparks; Neil M Johannsen; Timothy S Church; Conrad P Earnest; Esther Moonen-Kornips; Cedric Moro; Matthijs K C Hesselink; Steven R Smith; Patrick Schrauwen
Journal:  J Clin Endocrinol Metab       Date:  2013-03-05       Impact factor: 5.958

4.  Substrate metabolism during basal and hyperinsulinemic conditions in adolescents and young-adults with Barth syndrome.

Authors:  W Todd Cade; Carolyn T Spencer; Dominic N Reeds; Alan D Waggoner; Robert O'Connor; Melissa Maisenbacher; Jan R Crowley; Barry J Byrne; Linda R Peterson
Journal:  J Inherit Metab Dis       Date:  2012-05-12       Impact factor: 4.982

Review 5.  Therapeutic effects of sericin on diabetic keratopathy in Otsuka Long-Evans Tokushima Fatty rats.

Authors:  Noriaki Nagai; Yoshimasa Ito
Journal:  World J Diabetes       Date:  2013-12-15

6.  Reduced TCA Flux in Diabetic Myotubes: Determined by Single Defects?

Authors:  Michael Gaster
Journal:  Biochem Res Int       Date:  2012-03-18

7.  Biochemical evidence of cell starvation in diabetic hemodialysis patients.

Authors:  Masako Fujiwara; Itiro Ando; Keisuke Satoh; You Shishido; Kazuhito Totsune; Hiroshi Sato; Yutaka Imai
Journal:  PLoS One       Date:  2018-09-27       Impact factor: 3.240

8.  Intramuscular Injection of miR-1 Reduces Insulin Resistance in Obese Mice.

Authors:  Alice C Rodrigues; Alexandre R Spagnol; Flávia de Toledo Frias; Mariana de Mendonça; Hygor N Araújo; Dimitrius Guimarães; William J Silva; Anaysa Paola Bolin; Gilson Masahiro Murata; Leonardo Silveira
Journal:  Front Physiol       Date:  2021-07-06       Impact factor: 4.566

9.  T2D@ZJU: a knowledgebase integrating heterogeneous connections associated with type 2 diabetes mellitus.

Authors:  Zhenzhong Yang; Jihong Yang; Wei Liu; Leihong Wu; Li Xing; Yi Wang; Xiaohui Fan; Yiyu Cheng
Journal:  Database (Oxford)       Date:  2013-07-11       Impact factor: 3.451

10.  Metabolic signatures of cultured human adipocytes from metabolically healthy versus unhealthy obese individuals.

Authors:  Anja Böhm; Anna Halama; Tobias Meile; Marty Zdichavsky; Rainer Lehmann; Cora Weigert; Andreas Fritsche; Norbert Stefan; Alfred Königsrainer; Hans-Ulrich Häring; Martin Hrabě de Angelis; Jerzy Adamski; Harald Staiger
Journal:  PLoS One       Date:  2014-04-02       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.